Standards of Care for Type 2 Diabetes in China

Overview

Journal Diabetes Metab Res Rev

Specialty Endocrinology

Date 2016 Jul 28

PMID 27464265

Citations 152

Authors

Jianping Weng

Linong Ji

Weiping Jia

Juming Lu

Zhiguang Zhou

Dajin Zou

Dalong Zhu

Liming Chen

Li Chen

Lixin Guo

Xiaohui Guo

Qiuhe Ji

Qifu Li

Xiaoying Li

Jing Liu

Xingwu Ran

Zhongyan Shan

Lixin Shi

Guangyao Song

Liyong Yang

Yuzhi Yang

Wenying Yang

Affiliations

Soon will be listed here.

Citing Articles

Association Between Atherogenic, Thrombogenic, and Lipophilic Indices and the Odds of Diabetic Nephropathy in Type 2 Diabetic Patients: A Case-Control Study.

Abbasi B, Ghanbarzadeh E, Panahizadeh B Food Sci Nutr. 2025; 13(3):e4686.

PMID: 40041714 PMC: 11876850. DOI: 10.1002/fsn3.4686.

Alpha-glucosidase inhibitor decreases the risk of colorectal adenoma in the aged with Type 2 diabetes.

Xia D, Jin L, Wang B, Jin Y, Zheng Q, Xu J Sci Rep. 2025; 15(1):583.

PMID: 39748054 PMC: 11696837. DOI: 10.1038/s41598-024-84294-3.

Role of urinary trace elements in diabetic kidney disease: a cross-sectional analysis.

Gao T, Lv J, Lu L, Guo L, Tang W, Shao F BMJ Open Diabetes Res Care. 2024; 12(6.

PMID: 39706673 PMC: 11667472. DOI: 10.1136/bmjdrc-2024-004454.

Eliciting medication preferences of patients with type 2 diabetes under different insurance coverages in China.

Zheng L, Liu S, Liu Z, Cao C, Xue W, Chen Y Front Public Health. 2024; 12:1413642.

PMID: 39525467 PMC: 11544538. DOI: 10.3389/fpubh.2024.1413642.

Treatment Patterns and Glycaemic Control Between 2015 and 2019 in Tianjin, China: A Real-World Study of Adults with Type 2 Diabetes.

Zhang Q, Fan Y, Liu X, Zhang M, Zhang J, Du Q Diabetes Ther. 2024; 16(1):1-14.

PMID: 39487283 PMC: 11759750. DOI: 10.1007/s13300-024-01661-z.

References

Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D . Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005; (3):CD002966. DOI: 10.1002/14651858.CD002966.pub3. View

. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens. 1993; 11(3):309-17. DOI: 10.1097/00004872-199303000-00012. View

Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemio K . Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006; 368(9548):1673-9. DOI: 10.1016/S0140-6736(06)69701-8. View

Collins R, Armitage J, Parish S, Sleigh P, Peto R . MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003; 361(9374):2005-16. DOI: 10.1016/s0140-6736(03)13636-7. View

Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19):2560-72. DOI: 10.1001/jama.289.19.2560. View

Ilkova H, Glaser B, Tunckale A, Bagriacik N, Cerasi E . Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care. 1997; 20(9):1353-6. DOI: 10.2337/diacare.20.9.1353. View

Sever P, Poulter N, Dahlof B, Wedel H, Collins R, Beevers G . Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). Diabetes Care. 2005; 28(5):1151-7. DOI: 10.2337/diacare.28.5.1151. View

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Pan C, Yang W, Barona J, Niggli M, Mohideen P, Wang Y . Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial. Diabet Med. 2008; 25(4):435-41. DOI: 10.1111/j.1464-5491.2008.02391.x. View

10.

Pignone M, Alberts M, Colwell J, Cushman M, Inzucchi S, Mukherjee D . Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American.... Diabetes Care. 2010; 33(6):1395-402. PMC: 2875463. DOI: 10.2337/dc10-0555. View

11.

Snowling N, Hopkins W . Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care. 2006; 29(11):2518-27. DOI: 10.2337/dc06-1317. View

12.

Dhillon S, Weber J . Saxagliptin. Drugs. 2009; 69(15):2103-14. DOI: 10.2165/11201170-000000000-00000. View

13.

Guan H, Li Y, Xu Z, Li G, Guo X, Liu Z . Prevalence and risk factors of peripheral arterial disease in diabetic patients over 50 years old in China. Chin Med Sci J. 2007; 22(2):83-8. View

14.

Buse J, Ginsberg H, Bakris G, Clark N, Costa F, Eckel R . Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2006; 30(1):162-72. DOI: 10.2337/dc07-9917. View

15.

Jia W, Shen Q, Bao Y, Lu J, Li M, Xiang K . [Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy]. Zhonghua Yi Xue Za Zhi. 2007; 86(38):2707-10. View

16.

Nathan D, Cleary P, Backlund J, Genuth S, Lachin J, Orchard T . Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353(25):2643-53. PMC: 2637991. DOI: 10.1056/NEJMoa052187. View

17.

Lawes C, Parag V, Bennett D, Suh I, Lam T, Whitlock G . Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care. 2004; 27(12):2836-42. DOI: 10.2337/diacare.27.12.2836. View

18.

Cooper-DeHoff R, Gong Y, Handberg E, Bavry A, Denardo S, Bakris G . Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010; 304(1):61-8. PMC: 3008411. DOI: 10.1001/jama.2010.884. View

19.

Wilkinson C, Ferris 3rd F, Klein R, Lee P, Agardh C, Davis M . Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003; 110(9):1677-82. DOI: 10.1016/S0161-6420(03)00475-5. View

20.

Lu B, Song X, Dong X, Yang Y, Zhang Z, Wen J . High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. J Diabetes Complications. 2008; 22(2):96-103. DOI: 10.1016/j.jdiacomp.2007.08.001. View